These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

437 related articles for article (PubMed ID: 27747859)

  • 1. Curcumin as potential therapeutic natural product: a nanobiotechnological perspective.
    Shome S; Talukdar AD; Choudhury MD; Bhattacharya MK; Upadhyaya H
    J Pharm Pharmacol; 2016 Dec; 68(12):1481-1500. PubMed ID: 27747859
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Curcumin-loaded solid lipid nanoparticles with Brij78 and TPGS improved in vivo oral bioavailability and in situ intestinal absorption of curcumin.
    Ji H; Tang J; Li M; Ren J; Zheng N; Wu L
    Drug Deliv; 2016; 23(2):459-70. PubMed ID: 24892628
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Purely aqueous PLGA nanoparticulate formulations of curcumin exhibit enhanced anticancer activity with dependence on the combination of the carrier.
    Nair KL; Thulasidasan AK; Deepa G; Anto RJ; Kumar GS
    Int J Pharm; 2012 Apr; 425(1-2):44-52. PubMed ID: 22266528
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PLGA nanoparticles improve the oral bioavailability of curcumin in rats: characterizations and mechanisms.
    Xie X; Tao Q; Zou Y; Zhang F; Guo M; Wang Y; Wang H; Zhou Q; Yu S
    J Agric Food Chem; 2011 Sep; 59(17):9280-9. PubMed ID: 21797282
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel flavonoid-based biodegradable nanoparticles for effective oral delivery of etoposide by P-glycoprotein modulation: an in vitro, ex vivo and in vivo investigations.
    Fatma S; Talegaonkar S; Iqbal Z; Panda AK; Negi LM; Goswami DG; Tariq M
    Drug Deliv; 2016; 23(2):500-11. PubMed ID: 24937381
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic fate of poly-(lactic-co-glycolic acid)-based curcumin nanoparticles following oral administration.
    Harigae T; Nakagawa K; Miyazawa T; Inoue N; Kimura F; Ikeda I; Miyazawa T
    Int J Nanomedicine; 2016; 11():3009-22. PubMed ID: 27418823
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Orally administered nanocurcumin to attenuate morphine tolerance: comparison between negatively charged PLGA and partially and fully PEGylated nanoparticles.
    Shen H; Hu X; Szymusiak M; Wang ZJ; Liu Y
    Mol Pharm; 2013 Dec; 10(12):4546-51. PubMed ID: 24195658
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fabrication of curcumin encapsulated PLGA nanoparticles for improved therapeutic effects in metastatic cancer cells.
    Yallapu MM; Gupta BK; Jaggi M; Chauhan SC
    J Colloid Interface Sci; 2010 Nov; 351(1):19-29. PubMed ID: 20627257
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evolution of availability of curcumin inside poly-lactic-co-glycolic acid nanoparticles: impact on antioxidant and antinitrosant properties.
    Betbeder D; Lipka E; Howsam M; Carpentier R
    Int J Nanomedicine; 2015; 10():5355-66. PubMed ID: 26345627
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Curcumin loaded PLGA-poloxamer blend nanoparticles induce cell cycle arrest in mesothelioma cells.
    Mayol L; Serri C; Menale C; Crispi S; Piccolo MT; Mita L; Giarra S; Forte M; Saija A; Biondi M; Mita DG
    Eur J Pharm Biopharm; 2015 Jun; 93():37-45. PubMed ID: 25794477
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeted Nanocurcumin Therapy Using Annexin A2 Anitbody Improves Tumor Accumulation and Therapeutic Efficacy Against Highly Metastatic Breast Cancer.
    Mukerjee A; Ranjan AP; Vishwanatha JK
    J Biomed Nanotechnol; 2016 Jul; 12(7):1374-92. PubMed ID: 29336533
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polymeric Nano-Encapsulation of Curcumin Enhances its Anti-Cancer Activity in Breast (MDA-MB231) and Lung (A549) Cancer Cells Through Reduction in Expression of HIF-1α and Nuclear p65 (Rel A).
    Khan MN; Haggag YA; Lane ME; McCarron PA; Tambuwala MM
    Curr Drug Deliv; 2018 Feb; 15(2):286-295. PubMed ID: 29065834
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hansen solubility parameters (HSP) for prescreening formulation of solid lipid nanoparticles (SLN): in vitro testing of curcumin-loaded SLN in MCF-7 and BT-474 cell lines.
    Doktorovova S; Souto EB; Silva AM
    Pharm Dev Technol; 2018 Jan; 23(1):96-105. PubMed ID: 28949267
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of polymer molecular weight on relative oral bioavailability of curcumin.
    Tsai YM; Chang-Liao WL; Chien CF; Lin LC; Tsai TH
    Int J Nanomedicine; 2012; 7():2957-66. PubMed ID: 22745556
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost-effective alternative to nano-encapsulation: Amorphous curcumin-chitosan nanoparticle complex exhibiting high payload and supersaturation generation.
    Nguyen MH; Yu H; Kiew TY; Hadinoto K
    Eur J Pharm Biopharm; 2015 Oct; 96():1-10. PubMed ID: 26170159
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design and evaluation of poly(DL-lactic-co-glycolic acid) nanocomposite particles containing salmon calcitonin for inhalation.
    Yang M; Yamamoto H; Kurashima H; Takeuchi H; Yokoyama T; Tsujimoto H; Kawashima Y
    Eur J Pharm Sci; 2012 Aug; 46(5):374-80. PubMed ID: 22414702
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent progress in studying curcumin and its nano-preparations for cancer therapy.
    Liu J; Chen S; Lv L; Song L; Guo S; Huang S
    Curr Pharm Des; 2013; 19(11):1974-93. PubMed ID: 23116308
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anticancer drug-loaded quantum dots engineered polymeric nanoparticles: Diagnosis/therapy combined approach.
    Belletti D; Riva G; Luppi M; Tosi G; Forni F; Vandelli MA; Ruozi B; Pederzoli F
    Eur J Pharm Sci; 2017 Sep; 107():230-239. PubMed ID: 28728978
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis of Nanostructured Lipid Carriers Loaded Chitosan/ Carbopol Hybrid Nanocomposite Gel for Oral Delivery of Artemether and Curcumin.
    Kumar A; Behl T; Uniyal T; Chadha S
    Pharm Nanotechnol; 2020; 8(5):418-432. PubMed ID: 32895049
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug-loaded PLGA nanoparticles for oral administration: fundamental issues and challenges ahead.
    Kumar G; Shafiq N; Malhotra S
    Crit Rev Ther Drug Carrier Syst; 2012; 29(2):149-82. PubMed ID: 22475089
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.